Our results of decreased expression of SREBP1 mRNA and protein by the ATP7B inhibition is consistent with the findings in a recent publication of 45 WD patients with the lower levels of total cholesterol and LDL cholesterol compared with the control group [21], and reduced SREBP1 expression in liver of Atp7b knockout mice [22]. This evidence concerns the gene ATP7B and Wilson disease.